Correlate the following pediatric patient scenarios with the most appropriate targeted preventive care or immunization intervention.
- A 16-year-old adolescent with an inherited terminal complement pathway deficiency (C5-C9)Administer the serogroup B meningococcal (MenB) vaccine
- A healthy 1-year-old residing in a recently renovated urban apartment building constructed prior to 1960Evaluate blood lead levels using a capillary or venous sample
- A 2-year-old boy with homozygous sickle cell disease who has received all standard infant immunizationsAdminister the 23-valent pneumococcal polysaccharide vaccine (PPSV23)
- A 24-month-old asymptomatic toddler who recently relocated from a region with widespread endemic tuberculosisPerform screening with a tuberculin skin test or interferon-gamma release assay
Cevap
Match the complement deficiency to the MenB vaccine, the older housing exposure to lead screening, the sickle cell disease to the PPSV23 vaccination, and the endemic region emigration to tuberculosis screening.
High-risk pediatric patients require precise modifications to standard preventive care. Asplenia (seen in sickle cell disease) necessitates PPSV23 to protect against encapsulated bacteria. Complement deficiencies require MenB to prevent severe meningococcal disease. Specific environmental and geographic exposures mandate targeted screening for lead toxicity and tuberculosis, respectively.
Adım Adım Çözüm
Anahtar Kavram
Targeted preventive care and immunization schedules for high-risk pediatric populations.